Venclexta
Active Ingredient(s): VenetoclaxFDA Approved: * April 11, 2016
Pharm Company: * ABBVIE INC
Category: Cancer
Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML).[3][4] The most common side effects are low levels of neutrophils (a type of white blood cell), diarrhea, nausea, anemia (low red blood cell counts), nose and throat infection and tiredness.[4] Venetoclax attaches to a protein called Bcl-2.&... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.